Skip to Main Content

Author Details

Steven H Lin
University of Texas MD Anderson Cancer Center
2008
281
53
PMIDPaper TitleJournal TitlePublished Year
37652304Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.Int J Radiat Oncol Biol Phys2024
36411943On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happenings.Cancer Med2023
38023221Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models.Front Oncol2023
37479326Statin Use and Chemoradiation in Esophageal Squamous Cell Carcinomas: Ready for Prime Time?J Thorac Oncol2023
37478883Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.Lancet2023
37046782Independent Reproduction of the FLASH Effect on the Gastrointestinal Tract: A Multi-Institutional Comparative Study.Cancers (Basel)2023
37406827Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology.Int J Radiat Oncol Biol Phys2023
37268451Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.Lancet Digit Health2023
37332576Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors.Front Cardiovasc Med2023
36719597Causes of Clonal Hematopoiesis: a Review.Curr Oncol Rep2023
36716413Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals <i>EGFR</i> Mutations to Be Associated With Longer Overall Survival.JCO Precis Oncol2023
36739919Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations.Int J Radiat Oncol Biol Phys2023
36736591RE: Venkatesulu et al. (Letter to the Editor).Radiother Oncol2023
36931040Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions.Neoplasia2023
36762061Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.Transl Lung Cancer Res2023
36893753The abscopal effect in patients with cancer receiving immunotherapy.Med2023
36755027Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.Nat Commun2023
34800037Design and validation of a synchrotron proton beam line for FLASH radiotherapy preclinical research experiments.Med Phys2022
35774487Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy.Int J Part Ther2022
35675852A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases.Int J Radiat Oncol Biol Phys2022
35801078Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.J Cardiovasc Aging2022
35666500Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.JAMA Netw Open2022
35427556In Reply to Chow and Simone.Int J Radiat Oncol Biol Phys2022
35853442Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for FLASH experiments.Phys Med Biol2022
35687697ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.Sci Immunol2022
36516370Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy.JCO Precis Oncol2022
36426217Radiation therapy induces immunosenescence mediated by p90RSK.Front Cardiovasc Med2022
35973624Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.Int J Radiat Oncol Biol Phys2022
36371941Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.Lung Cancer2022
36209942Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer.Radiother Oncol2022
35928987Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy.Adv Radiat Oncol2022
35958323Expert consensus on perioperative treatment for non-small cell lung cancer.Transl Lung Cancer Res2022
36089921Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.JTO Clin Res Rep2022
35192118Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment.Curr Oncol Rep2022
35015316Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.Am J Hematol2022
34913815Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer.Acta Oncol2022
35243025The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis.Clin Transl Radiat Oncol2022
35307270Active Surveillance for Early Stage Lung Cancer.Clin Lung Cancer2022
35267613The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer.Cancers (Basel)2022
35058327Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy.J Immunother Cancer2022
35051703Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.Cancer Treat Res Commun2022
34897440Prolonged neutrophilia is associated with worse outcomes after Esophagectomy.Dis Esophagus2022
35229311A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy.Med Phys2022
34419375Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases.Clin Lung Cancer2022
32750703Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.Neuro Oncol2021
33681312Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway.Front Cardiovasc Med2021
33486102A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.Pract Radiat Oncol2021
33707003Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.Clin Lung Cancer2021
33705549Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.J Natl Cancer Inst2021
33837540Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions.Med Phys2021
  • 1 - 50 of 281

Recommended Authors

Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 1
Ali Hosni
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 1
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 3
Sara J Zakem
University of Washington
Career Start Year 2013
Number of shared co-authors 0
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 1
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 0
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 3
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 1
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 2
Hanbo Chen
University of Toronto
Career Start Year 2010
Number of shared co-authors 3
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 0
Michael Xiang
University of California los angeles
Career Start Year 2007
Number of shared co-authors 4
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 2
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Esther G C Troost
German Cancer Research Center (DKFZ)
Career Start Year 2003
Number of shared co-authors 3
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 1
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 5
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 10
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 2
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 5
Karyn A Goodman
Mount Sinai Hospital
Career Start Year 1996
Number of shared co-authors 1
Jong Hoon Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 5
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 4
Nasser K Altorki
New York-Presbyterian Hospital
Career Start Year 1983
Number of shared co-authors 4
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 4

Collaborators

Radhe Mohan
The University of Texas MD Anderson Cancer Center
Co-authored papers 32
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Co-authored papers 31
Brian P Hobbs
Dell Medical School, University of Texas at Austin
Co-authored papers 17
Peter Balter
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Lixia Diao
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Keri Schadler
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
John P Cooke
Co-authored papers 5
Bhanu Prasad Venkatesulu
Loyola University, Illinois Edward Hines Veteran Affairs Hospital
Co-authored papers 5
Minesh P Mehta
Co-authored papers 5
James M Reuben
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Cong Zhu
School of Public Health, The University of Texas Health Science Center at Houston
Co-authored papers 4
Qingyi Wei
South China University of Technology
Co-authored papers 4
Mien-Chie Hung
Co-authored papers 4
Junjie Chen
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Youqiong Ye
Co-authored papers 4
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Zhao Zhang
Co-authored papers 4
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Charles Lu
Co-authored papers 4
Laurence E Court
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Joost J C Verhoeff
University Medical Center Utrecht
Co-authored papers 4
Lifei Zhang
The University of Texas MD Anderson Cancer Center.
Co-authored papers 3
Angela B Y Hui
Stanford University
Co-authored papers 3
Jinzhong Yang
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Aadel A Chaudhuri
Co-authored papers 3
Nianxiang Zhang
Co-authored papers 3
Wenhua Cao
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Release 1.2